Abstract
A series of examples of the application of recombinant nucelic acid technology to the production of transgenic organisms is presented. The review considers the distinct advantages of producing certain recombinant biomolecules in appropriate eucaryotic systems rather than in the traditional procaryotic ones. Gene therapy in humans and the production of transgenic animals and plants are discussed. Concerns about the inadvertant construction of new pathogens and ethical considerations about interfereing with poorly understood ecosystems are addressed.
| Original language | English (Ireland) |
|---|---|
| Media of output | Reviews |
| Publisher | PERGAMON-ELSEVIER SCIENCE LTD |
| Volume | 12 |
| ISBN (Print) | 0734-9750 |
| ISBN (Electronic) | 0734-9750 |
| Publication status | Published - 1 Jan 1994 |